Zhao, Y., Griesel, R., Omar, Z., Simmons, B., Hill, A., van Zyl, G., . . . Meintjes, G. (2023). Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: A noncomparative, double-blind, randomized placebo-controlled trial. Oxford University Press.
Citazione stile Chigago Style (17a edizione)Zhao, Y., R. Griesel, Z. Omar, B. Simmons, A. Hill, G. van Zyl, C. Keene, G. Maartens, e G. Meintjes. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.
Citatione MLA (9a ed.)Zhao, Y., et al. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.